UltraGreen.ai’s post-IPO performance is an important gauge of investor interest
It represents the kind of high-tech players that investors have been clamouring to see listed on the local bourse
Add BT as a preferred source
[SINGAPORE] After years of lamenting the lack of high-tech, growth-focused companies on the Singapore Exchange (SGX), investors are getting their wish granted with the upcoming debut of UltraGreen.ai.
The company develops fluorescence-guided surgery technology, offers fluorescence imaging services and supplies indocyanine green dyes used in surgical procedures. More importantly, it represents the kind of high-tech players that investors have been clamouring to see listed on the local bourse.
UltraGreen.ai is laying the foundation for success with a high-powered board. Kwa Chong Seng, former SGX and ST Engineering chairman, is the non-independent non-executive chairman. Hsieh Fu Hua, former SGX CEO and once a director at Grab, is the lead independent director.
TRENDING NOW
Ohmyhome Ltd sells real estate business for token US$1 due to poor business and continued losses
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
Buyer for England striker Harry Kane’s former mansion must pay £3.4 million after abandoning deal
EU and Asean at 50: time for bold action
